Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

911037 Title: Préparation d'immunoglobulines pour injection intraveineuse pouvant être conservée à température ambiante

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
981197825
WO application number:
Type:
European patent granted for BE
Status:
Publication number:
911037
WO publication number:
1rst applicant's nationality:
Translation language:
French
EPO publication language:
English
SPC number:

Dates

Filing date:
23/10/1998
Grant date:
18/09/2002
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
21/11/2002
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
EP B1 publication date:
18/09/2002
EP B2 publication date:
13/06/2007
EP B3 publication date:
Lapsed date:
31/10/2006
Expiration date (if granted and all annual fees paid):

Applicant

Name:
Mitsubishi Pharma Corporation
Legal Form:
From:
18/09/2002
Address:
6-9 Hiranomachi 2-chome Chuo-ku Osaka-shi Osaka 541-0046(JP), JP
To:

Priority

Priority patent number:
29137497
Priority date:
23/10/1997
Priority country:
Japan (JP)

Classification

IPC or IDT classification:
A61K 39/395 ; C07K 16/06;

Publication

European Patent Bulletin

Issue number:
Publication date:
18/06/2003
Description:
Opposition procedure started

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
30/11/2005
Last annual fee paid number:
Payer:

Additional information section

Status:
ZONDER GEVOLG / SANS EFFET
Case kind / Max duration / Publication code:
Basic patent details (Patent law 1854):
Representative details:
KUBORN Jacques-OFFICE HANSSENS COLENS-Square Marie Louise, 40 Bte 19 - B 1000 BRUXELLES
Inventor(s) details:
Hirao, Yutaka, Yoshitomi Pharmaceutical Ind.;Hashimoto, Motonori, Yoshitomi Pharmaceutical Ind.;Kitamura, Tae, Yoshitomi Pharmaceutical Ind.;Uemura,Yahiro, Yoshitomi Pharmaceutical Ind.;
History of owners:
Filing date Document type Publication Type Document Description Number of pages File Type
21/11/2002 General Document (TO - T:Traduction Originale) 29 PDF /7/3/0/1/1/0510911037/migrated-docs/981197825_1_132919.pdf